Pharmacogenomics at Mayo Clinic

Pharmacogenomics at Mayo Clinic


Pharmacogenomics is a method used to determine how a specific individual will act in response to a specific drug through correlating gene expression or single-nucleotide polymorphisms with a drug’s toxicity (1). This area of study is finely tailored to the one patient’s genome; therefore the drugs administered will be more effective as well as at a proper dosage to combat whatever ailment is present (3). As of late, most drugs are available where millions of people are given the same exact drug; however, each individual’s body responds differently, thus the drug is either less or more effective based on the patient (3). 

The Future for PharmacogenomicsEdit

Pharmacogenomics remains in its infancy. Despite its recent discovery, pharmacogenomics is thought to be able to combat illnesses such as cancer, psychological disorders, and even HIV (1). This new area of research will allow for more personalized medicine improve treatment outcomes, decrease the incidence of drug-related adverse effects, and ultimately reduce the cost of medical care (2). 


(1) "Pharmacogenomics." Wikipedia, the free encyclopedia. Wikipedia, n.d. Web.

(2) Vali, J. "Pharmacogenomics: The End of Trial... [Int J Pharm Compd. 2007Jan-Feb] - PubMed - NCBI." National Center for Biotechnology Information. PubMed, n.d. Web.

(3) "What is pharmacogenomics? - Genetics Home Reference." Genetics HomeReference - Your guide to understanding genetic conditions. The National Institute of Health, 26 Aug. 2013. Web.